Stifel lowered the firm’s price target on Nyxoah (NYXH) to $15 from $16 and keeps a Buy rating on the shares. For the quarter, revenue was “light,” offset by better-than-expected gross margin, but “it is all about U.S. Genio approval and the subsequent ramp,” the analyst tells investors in an earnings recap note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH:
Questions or Comments about the article? Write to editor@tipranks.com